https://www.angeliniventures.com/2026-01-26daily1https://www.angeliniventures.com/vision/2023-04-18daily0.5https://www.angeliniventures.com/focus/2023-10-25daily0.5https://www.angeliniventures.com/approach/2026-01-26daily0.5https://www.angeliniventures.com/portfolio/2025-12-04daily0.5https://www.angeliniventures.com/portfolio/nobi/2025-10-16daily0.5https://www.angeliniventures.com/portfolio/neumirna/2025-09-19daily0.5https://www.angeliniventures.com/portfolio/nouscom-ag/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/noctrix-health/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/avation-medical/2025-10-24daily0.5https://www.angeliniventures.com/portfolio/cour-pharmaceutics/2025-02-05daily0.5https://www.angeliniventures.com/portfolio/freya-therapeutics/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/extend/2025-09-17daily0.5https://www.angeliniventures.com/portfolio/cadence-neuroscience/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/damona-pharmaceuticals/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/serenis/2025-10-20daily0.5https://www.angeliniventures.com/portfolio/arclight-therapeutics/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/congruence-therapeutics/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/genep/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/pretzel-therapeutics/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/argobio/2024-07-22daily0.5https://www.angeliniventures.com/portfolio/comind/2025-10-20daily0.5https://www.angeliniventures.com/portfolio/vantis/2025-05-13daily0.5https://www.angeliniventures.com/portfolio/nuevocor/2025-05-13daily0.5https://www.angeliniventures.com/portfolio/therinibio/2025-05-14daily0.5https://www.angeliniventures.com/portfolio/elkedonia/2025-06-10daily0.5https://www.angeliniventures.com/portfolio/nuclidium/2025-07-10daily0.5https://www.angeliniventures.com/portfolio/adcytherix/2025-10-16daily0.5https://www.angeliniventures.com/portfolio/laigo-bio/2025-12-04daily0.5https://www.angeliniventures.com/team/2026-03-10daily0.5https://www.angeliniventures.com/team/our-team/paolo-di-giorgio/2024-08-30daily0.5https://www.angeliniventures.com/team/our-team/elia-stupka/2025-05-06daily0.5https://www.angeliniventures.com/team/our-team/tanja-dowe/2025-01-28daily0.5https://www.angeliniventures.com/team/our-team/regina-hodits/2025-10-16daily0.5https://www.angeliniventures.com/team/our-team/gabriela-manrique/2023-07-05daily0.5https://www.angeliniventures.com/team/our-team/fabrizio-calisti/2025-06-11daily0.5https://www.angeliniventures.com/team/our-team/thomas-thestrup/2025-03-21daily0.5https://www.angeliniventures.com/team/our-team/nils-bottler/2025-03-12daily0.5https://www.angeliniventures.com/team/our-team/cesar-montero/2023-10-10daily0.5https://www.angeliniventures.com/team/our-team/barbara-saulini/2024-04-16daily0.5https://www.angeliniventures.com/team/our-team/natasa-ralevic/2026-02-09daily0.5https://www.angeliniventures.com/team/our-team/martina-palmese/2026-02-09daily0.5https://www.angeliniventures.com/team/our-team/maya-misra/2026-02-09daily0.5https://www.angeliniventures.com/team/our-team/lola-buono/2026-02-09daily0.5https://www.angeliniventures.com/team/our-team/sarah-fox/2025-06-04daily0.5https://www.angeliniventures.com/team/our-team/daniel-bode/2025-10-13daily0.5https://www.angeliniventures.com/team/our-team/hamzeh-abdul-hadi/2026-02-10daily0.5https://www.angeliniventures.com/team/our-team/gaia-mussi/2026-03-10daily0.5https://www.angeliniventures.com/team/board-of-directors/sergio-marullo-di-condojanni/2024-03-17daily0.5https://www.angeliniventures.com/team/board-of-directors/thea-paola-angelini/2026-01-07daily0.5https://www.angeliniventures.com/team/board-of-directors/lorenzo-tallarigo/2023-12-18daily0.5https://www.angeliniventures.com/team/board-of-directors/mark-muth/2023-12-18daily0.5https://www.angeliniventures.com/team/board-of-directors/jessica-federer/2023-12-18daily0.5https://www.angeliniventures.com/team/board-of-directors/matthias-evers/2025-03-27daily0.5https://www.angeliniventures.com/team/board-of-directors/roberta-cocco/2023-12-18daily0.5https://www.angeliniventures.com/history/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/2025-11-13daily0.5https://www.angeliniventures.com/insights-and-news/angelini-pharma-and-lumira-ventures-launch-the-angelini-lumira-biosciences-fund/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/lumira-ventures-announces-first-investment-from-the-angelini-lumira-bioscences-fund-in-genep/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/argobio-announces-its-launch-with-50-m-to-create-and-develop-pioneering-biotech-spinouts-with-the-support-of-bpifrance-kurma-partners-angelini-pharma-evotec-and-the-institut-pasteur/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/world-mental-health-day-2022/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/spotlight-story/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/pretzel-therapeutics/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/evotec-and-cdp-venture-capital-launch-translational-partnership-extend/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/angelini-ventures-invests-in-online-mental-health-platform-serenis/2023-04-18daily0.5https://www.angeliniventures.com/insights-and-news/announcing-the-cemm-angelini-ventures-healthy-lifespan-expansion-initiative/2023-07-05daily0.5https://www.angeliniventures.com/insights-and-news/angelini-ventures-hosts-the-first-demo-day-of-vita/2023-04-19daily0.5https://www.angeliniventures.com/insights-and-news/dowe-moves-to-angelini-ventures/2023-12-06daily0.5https://www.angeliniventures.com/insights-and-news/cadence-neuroscience-secures-26-million-in-series-b-financing-for-clinical-trials-of-epilepsy-neuromodulation-therapy/2023-07-05daily0.5https://www.angeliniventures.com/insights-and-news/reflecting-on-angelini-ventures-inaugural-year-an-interview-with-paolo-di-giorgio-by-giovanni-iozzia-editor-in-chief-of-economyup/2023-12-13daily0.5https://www.angeliniventures.com/insights-and-news/freya-biosciences-announces-38-million-funding/2023-12-13daily0.5https://www.angeliniventures.com/insights-and-news/paolo-di-giorgio-featured-on-idee-geniali-podcast/2023-12-14daily0.5https://www.angeliniventures.com/insights-and-news/wired-italia-reveals-angelini-ventures-visionary-strategy/2024-01-11daily0.5https://www.angeliniventures.com/insights-and-news/angelini-ventures-invests-in-noctrix/2024-01-23daily0.5https://www.angeliniventures.com/insights-and-news/angelini-ventures-invests-in-cour-pharmaceuticals/2024-01-30daily0.5https://www.angeliniventures.com/insights-and-news/serenis-featured-in-stories-behind-the-change-the-first-podcast-by-angelini-industries/2024-02-01daily0.5https://www.angeliniventures.com/insights-and-news/avation-medical-investment/2024-02-05daily0.5https://www.angeliniventures.com/insights-and-news/paolo-di-giorgio-interview-innlifes/2024-02-12daily0.5https://www.angeliniventures.com/insights-and-news/angelini-ventures-joins-758-million-series-c-investment-in-nouscom/2024-03-21daily0.5https://www.angeliniventures.com/insights-and-news/angelini-holding-approves-consolidated-financial-statements-for-fy-2023/2024-07-25daily0.5https://www.angeliniventures.com/insights-and-news/cour-pharmaceuticals-is-one-of-the-biotech-fierce-15/2024-08-28daily0.5https://www.angeliniventures.com/insights-and-news/our-medical-director-discusses-healthcare-strategies-on-biotechtv/2024-10-21daily0.5https://www.angeliniventures.com/insights-and-news/lola-buono-on-radio-24-podcast/2024-10-25daily0.5https://www.angeliniventures.com/insights-and-news/esg-plan/2024-12-11daily0.5https://www.angeliniventures.com/insights-and-news/fda-approves-damona-clinical-trial/2024-11-10daily0.5https://www.angeliniventures.com/insights-and-news/neumirna-investment/2025-01-28daily0.5https://www.angeliniventures.com/insights-and-news/nobi-investment/2025-01-28daily0.5https://www.angeliniventures.com/insights-and-news/vantis-investment/2025-03-12daily0.5https://www.angeliniventures.com/insights-and-news/regina-hodits-appointment/2025-04-07daily0.5https://www.angeliniventures.com/insights-and-news/investment-manager-recruitment/2025-04-24daily0.5https://www.angeliniventures.com/insights-and-news/nuevocor-investment/2025-05-06daily0.5https://www.angeliniventures.com/insights-and-news/therini-bio-investment/2025-05-14daily0.5https://www.angeliniventures.com/insights-and-news/elkedonia-investment/2025-06-11daily0.5https://www.angeliniventures.com/insights-and-news/nuclidium-investment/2025-07-10daily0.5https://www.angeliniventures.com/insights-and-news/therinis-first-patient/2025-07-29daily0.5https://www.angeliniventures.com/insights-and-news/adcytherix-investment/2025-10-17daily0.5https://www.angeliniventures.com/insights-and-news/serenis-follow-on/2025-10-17daily0.5https://www.angeliniventures.com/insights-and-news/comind-investment/2025-10-20daily0.5https://www.angeliniventures.com/insights-and-news/singapore-office/2026-02-25daily0.5https://www.angeliniventures.com/insights-and-news/freya-on-clavirate-report/2025-11-18daily0.5https://www.angeliniventures.com/insights-and-news/laigo-bio-investment/2025-12-04daily0.5https://www.angeliniventures.com/insights-and-news/eib-av-partnership/2025-12-02daily0.5https://www.angeliniventures.com/insights-and-news/enodia-therapeutics-closes-207m-round/2026-01-08daily0.5https://www.angeliniventures.com/insights-and-news/plattform-life-sciences/2026-03-02daily0.5https://www.angeliniventures.com/authors/category-1/dr-werner-lanthaler/2023-04-18daily0.5https://www.angeliniventures.com/authors/category-1/enrico-resmini/2023-04-18daily0.5https://www.angeliniventures.com/authors/category-1/prof-sergio-marullo-di-condojanni/2023-04-19daily0.5https://www.angeliniventures.com/authors/category-1/silvia-wang/2023-04-18daily0.5https://www.angeliniventures.com/authors/category-1/filippo-piazza/2023-04-19daily0.5https://www.angeliniventures.com/authors/category-1/paolo-di-giorgio/2025-04-07daily0.5https://www.angeliniventures.com/authors/category-1/giulio-superti-furga/2023-04-19daily0.5https://www.angeliniventures.com/authors/category-1/stefano-molino/2023-04-19daily0.5https://www.angeliniventures.com/authors/category-1/paolo-borella/2023-04-19daily0.5https://www.angeliniventures.com/authors/category-1/alessandro-porcu/2023-04-19daily0.5https://www.angeliniventures.com/authors/category-1/kent-leyde/2023-07-05daily0.5https://www.angeliniventures.com/authors/category-1/gerry-brunk/2023-07-05daily0.5https://www.angeliniventures.com/authors/category-1/kevin-chu/2023-07-05daily0.5https://www.angeliniventures.com/authors/category-1/regina-hodits/2025-04-07daily0.5https://www.angeliniventures.com/authors/media-contact-evotec-se/gabriele-hansen/2023-04-18daily0.5https://www.angeliniventures.com/authors/media-contact-evotec-se/hinnerk-rohwedder/2023-04-18daily0.5https://www.angeliniventures.com/authors/ir-contact-evotec-se/volker-braun/2023-04-18daily0.5https://www.angeliniventures.com/authors/colleen-acosta/2023-12-12daily0.5https://www.angeliniventures.com/authors/shriram-raghunathan-phd/2024-01-03daily0.5https://www.angeliniventures.com/authors/john-j-puisis/2024-01-23daily0.5https://www.angeliniventures.com/authors/jill-schiaparelli-avation-medical/2024-02-02daily0.5https://www.angeliniventures.com/authors/marina-udier/2024-03-21daily0.5https://www.angeliniventures.com/authors/elia-stupka/2025-05-05daily0.5https://www.angeliniventures.com/authors/thomas-thestrup/2025-05-13daily0.5https://www.angeliniventures.com/cookie-policy/2025-11-06daily0.5https://www.angeliniventures.com/privacy-policy/2025-11-06daily0.5https://www.angeliniventures.com/terms-of-use_old/2023-04-18daily0.5https://www.angeliniventures.com/terms-of-use/2024-05-30daily0.5https://www.angeliniventures.com/careers/2024-01-08daily0.5https://www.angeliniventures.com/fellowship-program/2026-02-27daily0.5https://www.angeliniventures.com/sitemap/2023-04-18daily0.5https://www.angeliniventures.com/portfolio_old/2024-11-07daily0.5https://www.angeliniventures.com/webscraping/2024-05-30daily0.5https://www.angeliniventures.com/elisa-scarselli-nouscom-chief-scientific-officer/2024-09-11daily0.5https://www.angeliniventures.com/tanja-dowe-angelini-ventures-managing-director/2024-09-11daily0.5https://www.angeliniventures.com/accessibility-statement/2025-12-19daily0.5